Logo of nihpaAbout Author manuscripts Submit a manuscript HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Obesity (Silver Spring). Author manuscript; available in PMC 2013 Jan 1.
Published in final edited form as:
PMCID: PMC3319030
NIHMSID: NIHMS363839
PMID: 21836642

Evaluation of Specific Metabolic Rates of Major Organs and Tissues: Comparison Between Nonobese and Obese Women

Abstract

Elia (1992) identified the specific resting metabolic rates (Ki) of major organs and tissues in young adults with normal weight: 200 for liver, 240 for brain, 440 for heart and kidneys, 13 for skeletal muscle, 4.5 for adipose tissue and 12 for residual mass (all units in kcal/kg per day). The aim of the present study was to assess the applicability of Elia’s Ki values for obese adults. A sample of young women (n = 80) was divided into two groups, nonobese (BMI <29.9 kg/m2) and obese (BMI 30.0–43.2 kg/m2). This study was based on the mechanistic model: REE = Σ (Ki × Ti), where REE is whole-body resting energy expenditure measured by indirect calorimetry and Ti is the mass of individual organs and tissues measured by magnetic resonance imaging. For each organ/tissue, the corresponding Elia’s Ki value was analyzed respectively for nonobese and obese groups by using stepwise univariate regression analysis. Elia’s Ki values were within the range of 95% confidence intervals (CIs) in the nonobese group. However, Elia’s Ki values were outside the right boundaries of 95% CIs in the obese group and a corresponding obesity-adjusted coefficient was calculated as 0.98, indicating that Elia’s values overestimate Ki by 2.0% in obese adults. Obesity-adjusted Ki values were 196 for liver, 235 for brain, 431 for heart and kidneys, 12.7 for skeletal muscle, 4.4 for adipose tissue, and 11.8 for residual mass. In conclusion, although Elia’s Ki values were validated in nonobese women, obesity-adjustments are appropriate for application in obese women.

INTRODUCTION

One of the primary aims of human energy metabolism research is to explore the specific resting metabolic rate (i.e., Ki value) for individual organs and tissues. Estimating Ki values forms the basis for understanding daily energy requirements in humans, and for exploring the associations between resting energy expenditure (REE) and body composition (13).

Based on reported experimental results in humans and other mammals, Elia (1) presented a review on the Ki values for seven organs and tissues in young adults with normal body weight, including 200 for liver, 240 for brain, 440 for heart and kidneys, 13 for skeletal muscle, 4.5 for adipose tissue, and 12 for residual mass (all units are in kcal/kg per day). Residual mass includes skeleton, blood, skin, gastrointestinal tract, lung, spleen, and other organs and tissues present in small amounts. According to Elia, heart and kidneys have the highest Ki values, twice those for liver and brain. In contrast, the Ki value of skeletal muscle is only 1/35 that of heart and kidneys. Adipose tissue has the lowest Ki value among the seven organs and tissues.

Elia’s study assumed that the Ki values of major organs and tissues are stable across all adults. However, previous studies suggested that some biological factors influence the Ki values, including growth, development and aging (36).

Adiposity is a major source of variations in body composition and physiological function. Adiposity difference between normal-weight and obese subjects influences body composition per se (e.g., fat mass and fat-free mass) and related physiological functions (e.g., mass-specific REE). However, it remains unclear whether obesity influences the Ki values of major organs and tissues.

The aim of the present study was to critically compare the applicability of Elia’s Ki values between nonobese and obese young women.

METHODS AND PROCEDURES

Model development

In this study, we applied an approach that combines a mechanistic REE model with stepwise univariate regression analysis.

Mechanistic REE model

The mechanistic model assumes that whole-body REE is equal to the sum of the products of individual organ/tissue mass and their corresponding specific resting metabolic rates (7,8),

REE = ∑ (Ki × Ti)
(1)

where i (i = 1, 2, …, n) indicates individual organ and tissue; Ti is the corresponding mass; and Ki is its specific metabolic rate at rest.

Seven components, including four organs (i.e., liver, brain, heart, and kidneys), two tissues (i.e., skeletal muscle and adipose tissue) and the residuals were considered in equation 1. The rational of this approach is that the four organs have the highest Ki values and the two tissues are the largest components at the organ-tissue level. The following body composition model was thus applied,

BM = TliverTbrainTheartTkidneysTSMTATTresidual
(2)

where BM is body mass, and TSM and TAT are the mass of skeletal muscle and adipose tissue, respectively. Residual mass was obtained as BM minus the sum of liver, brain, heart, kidneys, skeletal muscle, and adipose tissue masses.

Substituting Elia’ Ki values into equation 1, a working REE model was derived,

REE = 200Tliver + 240Tbrain + 440Theart + 440Tkidneys + 13TSM + 4.5TAT + 12Tresidual
(3)

Stepwise univariate regression models

In the present study, we evaluated each Elia’s Ki value separately. Specifically, we performed a statistical analysis on Ki, when holding the remaining Ki at the values suggested by Elia (1). We constructed marginal 95% confidence intervals (CIs) for each of the seven Ki values via univariate linear regression analysis (9).

Our procedure can be described as follows. For liver we held Kbrain, Kheart, Kkidneys, KSM, KAT and Kresidual at 240, 440, 440, 13, 4.5, and 12, respectively. We then evaluated the specific metabolic rate of liver (Kliver) with the statistical hypothesis Kliver = 200 suggested by Elia (1). With equation 3, we fitted a linear regression model to our data to determine Kliver,

REE = Kliver × Tliver + 240Tbrain + 440Theart + 440Tkidneys + 13TSM + 4.5TAT + 12Tresidual
(4)

Standard least squares method yields an estimate with standard error (95% CIs) for Kliver separately for the nonobese and obese groups. The resulting 95% CIs were compared with the hypothesized Kliver value suggested by Elia. Testing the statistical hypothesis Kliver = 200 at a significance level of 0.05 was tantamount to checking whether Kliver = 200 falls inside the 95% CIs.

The equation 4 can also be rewritten as REEliver = Kliver × Tliver, by letting REEliver = REE-(240Tbrain + 440Theart + 440Tkidneys + 13TSM + 4.5TAT + 12Tresidual), the marginal energy of liver. Therefore, we calculated the following marginal R2 and R2★ by using Kliver in equation 4 and Elia’s K value (200) respectively,

R2(liver) = 1 − (REEliverKliver×Tliver)2/(REEliver)2
(5)
R2★(liver) = 1 − (REEliver−200Tliver)2/(REEliver)2.
(6)

The same procedure was repeated for each of the other six Ki values (i.e., Kbrain, Kheart, Kkidney, KSM, KAT and Kresidual) in the nonobese and obese women.

Adiposity-stratified Ki value model

The working REE model (equation 3) is based on an assumption that the Ki values of individual organs and tissues are stable across all healthy adults. In the present study, the subjects were divided into two groups, nonobese and obese, in order to assess the potential influence of adiposity on the Ki values. We consider the following adiposity-stratified REE model,

REE = ∑(Oi × Elia’s Ki × Ti)
(7)

where Oi represents the adiposity-adjusted coefficient for Elia’s Ki values. In this study, we made an assumption that the adiposity-adjusted coefficients are the same across all organs and tissues for each group, i.e., Oi = O. In other words, we applied a simplified adiposity-stratified REE model,

REE = O × (200Tliver + 240Tbrain + 440Theart + 440Tkidneys + 13TSM + 4.5TAT + 12Tresidual)
(8)

Once the O values in equation 8 were estimated by fitting a univariate linear regression, an adiposity-adjusted Ki values can be calculated for the nonobese and obese groups, respectively,

Adiposity − adjusted KiO × Elia’s Ki
(9)

Subjects

REE-organ/tissue subject data were collected at the Institute of Human Nutrition and Food Science, Christian-Alberchts University, Kiel, Germany. All of the subjects participated in earlier reported studies (10,11). The approvals of institutional review boards were obtained for all of the studies and subjects signed an informed consent. In order to exclude the potential influences of growth, development, aging, gender, race and diseases on the Ki values, only nonelderly (20–49 years) healthy female subjects were included in this study. All subjects were white women (n = 80) who were divided into two groups, nonobese (n = 51, BMI <29.9 kg/m2) and obese (n = 29, BMI ≥30 kg/m2).

Body composition

Body mass was measured to the nearest 0.1 kg in fasting subjects wearing minimal clothing. Height was measured with a stadiometer to the nearest 0.1 cm.

The volumes of six organs and tissues (i.e., liver, brain, heart, kidneys, skeletal muscle, and adipose tissue) were obtained by summing pixels from images obtained with a 1.5-T Magnetom Vision scanner (Siemens, Erlangen, Germany). The magnetic resonance imaging (MRI) protocol details have been previously described in detail elsewhere (10,12). All MRI images were segmented manually (TomoVision 4.3 Software; Slice-O-Matic, Montreal, Quebec, Canada). Each organ and tissue was analyzed by the same observer who was blinded to the time point and subject identity. The intra-observer coefficients of variation based on comparison of repeated segmentations were 0.07% for liver, 1.8% for brain, 1.7% for heart, and 1.0% for kidneys. The technical errors for measurement of the same scan on two separate days by the same observer of MRI-derived SM and AT volumes are 0.7 ± 0.1% and 1.1 ± 1.2% (mean ± s.d.), respectively.

Organ and tissue mass was calculated as the sum of all cross-sectional areas multiplied by the slice thickness and slice gaps,

Oragan/tissue mass = d × (tg) × ∑((SiSi + 1)/2)
(10)

where S is the organ/tissue cross-sectional area; i is the image number; t is the thickness of each image; g is the gap (distance) between consecutive images, and d is the density of each organ and tissue.

Total body fat mass was measured with a dual-energy X-ray absorptiometry scan (Hologic QDR 4500A; Hologic, Waltham, MA, software version V8.26a:3). Subjects lay supine with arms and legs at their sides during the 10-min scanning. The between-measurement technical error for fat in the same subject is 1.2%. In some subjects skeletal muscle and adipose tissue masses were calculated from dual-energy X-ray absorp-tiometry-estimation, as previously described (10). Skeletal muscle mass was predicted from appendicular lean-soft tissue (13); and adipose tissue mass was predicted from fat mass, assuming a stable fat content of 80% (14).

REE

In the present study, indirect calorimetry technique was applied to estimate REE with subjects in a postabsorptive state. The REE protocol details have been previously described in detail elsewhere (10). No food or calorie containing beverages were consumed after 7:00 pm until the REE and all body composition tests were completed the following morning. REE was measured between 7:00 amand 9:00 amwith subjects resting comfortably on a bed with a plastic transparent ventilated hood placed over their heads for 30 min. Continuous gas exchange measurements (Vmax Spectra 29n; SensorMedics, Bilthoven, Netherlands) were made to analyze the rates of O2 consumption and CO2 production.

Statistical analysis

Group means and their s.d. of body composition and REE were calculated. Two-sided Student’s t tests at a statistical significance level of 0.05 were used to test the differences in body composition and REE between the nonobese and obese groups. Elia’s Ki values for the seven organs and tissues were applied to predict REE and examine the association between measured REE (REEm) and predicted REE (REEp) by means of simple linear regression analysis. The marginal 95% CIs for the seven Ki values were constructed via stepwise univariate linear regression analysis (9). The database was analyzed by programming in R, version 2.10.0, a software for statistical computing and graphics initially written by Robert Gentleman and Ross Ihaka, Statistics Department, University of Auckland (Auckland, New Zealand) (15).

RESULTS

Subject characteristics and body composition

The characteristics and body composition of the two groups are presented in Table 1. Body mass, BMI, fat mass and %fat were all significantly different between the two groups (non-obese group < obese group, all P < 0.001). However, there were no significant differences in age, height and bone mineral contents between the two groups.

Table 1

Baseline subject characteristics

Nonobese women Obese women P
n 51 29
Age (years) 32.7 ± 8.1 33.3 ± 6.9 0.74
Body mass (kg) 65.8 ± 9.0 100.2 ± 16.9 <0.001
Height (m) 1.69 ± 0.06 1.68 ± 0.07 0.44
BMI (kg/m2) 22.9 ± 2.8 35.1 ± 3.8 <0.001
Fat mass (kg) 19.7 ± 5.8 43.0 ± 9.1 <0.001
%Fat 30.0 ± 6.3 43.2 ± 3.4 <0.001
BMC (kg) 2.32 ± 0.31 2.40 ± 0.24 0.23

All values are mean ± s.d. P value, t test for significant difference between the nonobese and obese women.

%fat, percentage of body mass as fat mass; BMC, bone mineral content.

The masses of four high metabolic rate organs (i.e., liver, brain, heart, and kidneys) and three low metabolic rate tissues (i.e., skeletal muscle, adipose tissue, and residual mass) are presented in Table 2. There were significant differences in all seven organs and tissues between the two groups (nonobese group < obese group, all P < 0.001).

Table 2

Organ/tissue mass and REE results

Nonobese women Obese women P
Liver (kg) 1.27 ± 0.18 1.69 ± 0.30 <0.001
Brain (kg) 1.27 ± 0.08 1.41 ± 0.13 <0.001
Heart (kg) 0.26 ± 0.05 0.32 ± 0.06 <0.001
Kidneys (kg) 0.25 ± 0.04 0.35 ± 0.07 <0.001
Skeletal muscle (kg) 21.4 ± 3.2 25.5 ± 4.1 <0.001
Adipose tissue (kg) 20.9 ± 5.7 44.0 ± 9.4 <0.001
Residual mass (kg) 20.6 ± 3.0 26.8 ± 5.0 <0.001
REEm (kcal/day) 1409 ± 139 1788 ± 229 <0.001
REEp (kcal/day) 1402 ± 132 1822 ± 239 <0.001
REEm – REEp (kcal/day) 7 ± 67 −34 ± 78 0.34

Measured and predicted REE

The REEm values for the two groups are reported in Table 2. The REEm in the nonobese women was significantly lower than that in the obese women (1,409 ± 139 vs. 1,788 ± 229 kcal/day, P < 0.001). According to equation 3, the REEp was 1,402 ± 132 kcal/day for the nonobese women and 1,822 ± 239 kcal/day for the obese women (Table 2). The REEm were correlated with REEp in both groups (Figure 1a,b). Although the (REEm – REEp) was not significantly different from 0 in the nonobese women (7 ± 67 kcal/day, P = 0.46), the (REEm – REEp) was significant in the obese women (−34 ± 78 kcal/day, P = 0.025). The plots between (REEm – REEp) and adiposity for all subjects pooled show that (REEm – REEp) is negatively correlated with both BMI (r = −0.31, P < 0.01; Figure 2a) and %fat (r = −0.276, P < 0.05; Figure 2b).

Measured resting energy expenditure (REEm, in kcal/day) vs. predicted REE (REEp) for the (a) nonobese women and (b) obese women. REEp were calculated by the Ki values suggested by Elia (1), according to equation 3. The lines of identity are shown. (a) REEm = 0.925 × REEp + 112, r = 0.879, P < 0.001, n = 51 nonobese women. (b) REEm = 0.906 × REEp + 138, r = 0.946, P < 0.001, n = 29 obese women.

The difference between measured and predicted resting energy expenditure (REEm – REEp, in kcal/day) vs. (a) BMI (in kg/m2) and (b) %fat for all subjects (n = 80). REEp was calculated using the Ki values suggested by Elia (1), according to equation 3. The zero difference line and the lines representing 2 s.d. for the REE differences (−155 and 139 kcal/day) are shown. (a) (REEm – REEp) = 85.7 − 3.43 × BMI; r = −0.314, P < 0.01. (b) (REEm – REEp) = 34.7 − 1.52 × %fat; r = −0.276, P < 0.05.

Evaluation of Ki values

We thus further evaluated the applicability of Elia’s Ki values in the two groups. By using stepwise univariate analysis, the 95% CIs of individual Ki values were calculated (Table 3). For the nonobese women, Elia’s Ki values were located within the 95% CIs for each of the seven organs and tissues. For the obese group, however, Elia’s Ki values were outside the right boundaries of 95% CIs for all seven organs and tissues (Figure 3). The coefficients of determination, R2 and R2★, were calculated (Table 4) as the proportion of marginal variability reduction due to each marginal model of respective organ/tissues.

95% Confidence intervals (CIs) for the Ki values of seven organs and tissues, fitted by stepwise univariate analysis are shown on a logarithmic scale, for the nonobese women (upper line) and the obese women (lower line). The Xs represent the Ki values suggested by Elia (1). AT, adipose tissue; Res, residual mass; SM, skeletal muscle.

Table 3

95% Confidence intervals of Ki of organs and tissues

Organ/Tissue Elia’s Ki value 95% Confidence intervals of Ki and P value
Nonobese women Obese women
Liver 200 191, 220 163, 196
P = 0.49 P = 0.017
Brain 240 230, 260 194, 234
P = 0.49 P = 0.011
Heart 440 388, 532 232, 402
P = 0.58 P = 0.005
Kidneys 440 381, 528 252, 411
P = 0.70 P = 0.008
Skeletal muscle 13 12.4, 14.2 10.5, 12.7
P = 0.48 P = 0.013
Adipose tissue 4.5 3.9, 5.6 3.1, 4.4
P = 0.56 P = 0.022
Residual mass 12 11.4, 13.2 9.6, 11.7
P = 0.55 P = 0.012

All units of Ki values are in kcal/kg per day. P, P value of testing H0: Ki equals to the coefficient suggested by Elia (1).

Table 4

Coefficients of determination for each marginal model

Organ/Tissue Elia’s Ki valuea Marginal R2 and R2★b
All subjects Nonobese women Obese women
Liver 200 R2 = 0.94 R2 = 0.94 R2 = 0.94
R2★ = 0.94 R2★ = 0.94 R2★ = 0.93
Brain 240 R2 = 0.95 R2 = 0.96 R2 = 0.94
R2★ = 0.95 R2★ = 0.96 R2★ = 0.93
Heart 440 R2 = 0.71 R2 = 0.77 R2 = 0.67
R2★ = 0.70 R2★ = 0.76 R2★ = 0.60
Kidneys 440 R2 = 0.72 R2 = 0.75 R2 = 0.67
R2★ = 0.71 R2★ = 0.75 R2★ = 0.64
SM 13 R2 = 0.94 R2 = 0.95 R2 = 0.94
R2★ = 0.94 R2★ = 0.95 R2★ = 0.93
AT 4.5 R2 = 0.77 R2 = 0.71 R2 = 0.83
R2★ = 0.76 R2★ = 0.70 R2★ = 0.80
Residual mass 12 R2 = 0.93 R2 = 0.94 R2 = 0.94
R2★ = 0.93 R2★ = 0.94 R2★ = 0.92

AT, adipose tissue; SM, skeletal muscle.

aAll units of Ki values are in kcal/kg per day.
bR2: the proportion of marginal variability reduction by fitting marginal model of respective organ/tissue. To make comparisons, the proportion of marginal variability reduction by directly applying Elia’s coefficient was calculated as R2★.

Based on equation 8, adiposity-adjusted coefficient of the nonobese group was calculated as O = 1.004 (P = 0.52) that is not significantly different from 1. On the contrary, adiposity-adjusted coefficients of the obese group was O = 0.980 (P = 0.012) that is significantly different from 1. A simplified model with a unified parameter O for all women resulted in an estimate O = 0.992 (P = 0.142). By comparing Akaike information criterion (16) and performing ANOVA test (Table 5), the adiposity-stratified model 8 is preferred and thus, adiposity adjustment is necessary for Elia’s Ki values for obese women. According to equation 9, the obesity-adjusted Ki values were 196 for liver, 235 for brain, 431 for heart and kidneys, 12.7 for skeletal muscle, 4.4 for adipose tissue, and 11.8 for residual mass (all in kcal/kg per day, Table 6).

Table 5

Adiposity-stratified model and un-stratified model

Model Coefficient O P value AICa df ANOVAb
All sample 0.992 (0.982, 1.003) 0.142 916 1 0.018
(P < 0.05)
Adiposity-Stratified 1.004 (0.990, 1.018)c 0.544 912 2
0.980 (0.966, 0.994)d 0.006
aAkaike information criterion (AIC); a model with a smaller AIC is preferred.
bA goodness-of-fit test.
c%95 confidence interval (CI) for nonobese women (n = 51).
d%95 CI for obese women (n = 29).

Table 6

Adiposity-adjusted organ and tissue specific metabolic rates (Ki) and their 95% confidence intervals (CIs)

Organ/Tissue Elia’s Ki value Adiposity-adjusted Ki values and (95% CIs)
Nonobese women Obese women
Liver 200 201 (198, 204) 196 (193, 199)
Brain 240 241 (238, 244) 235 (231, 239)
Heart 440 442 (436, 448) 431 (424, 438)
Kidneys 440 442 (436, 448) 431 (424, 438)
Skeletal muscle 13 13.1 (12.9, 13.2) 12.7 (12.5, 12.9)
Adipose tissue 4.5 4.52 (4.46, 4.58) 4.41 (4.34, 4.48)
Residual mass 12 12.1 (11.9, 12.2) 11.8 (11.6, 12.0)

All units of Ki values are in kcal/kg per day.

DISCUSSION

The present study applied two approaches to evaluate the applicability of Elia’s Ki values in obese adults. The first approach was to compare REEp with REEm, in which REEp is calculated by equation 3 with Elia’s Ki values. If the REEm – REEp difference is not significantly different from zero, we may consider that Elia’s Ki values are applicable for this group.

For the nonobese women, the REEp and REEm were in good correlation (r = 0.88, P < 0.001), and the REEm – REEp difference (7 ± 67 kcal/day) was not significantly different from zero (P = 0.46), supporting the applicability of Elia’s Ki values. These results were confirmed by previous observations for young adults with normal weight (7,10). Another study also suggested no evidence for the mass dependency of Ki values in subjects with a normal fat mass (11). Our results showed that Elia’s Ki values were located within the 95% CIs for the nonobese young women, further validating the applicability of Elia’s Ki values in nonobese women.

For the obese women, REEp were significantly higher than REEm by 34 ± 78 kcal/day or 1.9% (P = 0.025), revealing that Elia’s study overestimated actual Ki values in the obese group. Moreover, we found that there were negative correlations between (REEm – REEp) and adiposity, either in terms of BMI (r = −0.314, P < 0.01; Figure 2a) or %fat (r = −0.276, P < 0.05; Figure 2a), suggesting that actual Ki values with greater adiposity should be lower than that suggested by Elia. In order to further evaluate the applicability of Elia’s Ki values in obese adults, another approach was applied with stepwise univariate analysis. Elia’s Ki values were outside the right boundary of the 95% CIs for the seven organs and tissues (Figure 3). This observation demonstrates that Elia’s Ki values overestimate actual Ki values in obese adults. Although the amount of drop in each Ki value is likely to be overly stated because of the marginal approach, our proposed model as specified by equations 8 and 9 distribute the total drop proportionally to all the organs via an obesity-adjusted coefficient (O = 0.980, P = 0.012). This coefficient O may therefore be interpreted as the average effect of adiposity and should be applied for this group of adults (Tables 5 and and66).

As with the organ-tissue level REE model (i.e., equation 1), REE can be expressed at the cellular level (8),

REE = ∑(Ji × Ci)
(11)

where C is the mass of individual cell categories; i is the cell category number (i = 1, 2, …, n); and J is the specific resting metabolic rate of individual cell categories. Equation 11 reveals that the magnitude of REE is determined by the mass of individual cell categories (Ci) and their corresponding Ji values. Given an individual organ/tissue, the following model can be derived linking the organ-tissue level with the cellular level,

Ki × TiJi × Ci or KiJi × (Ci/Ti)
(12)

where (Ci/Ti) represents the cellularity of individual organ and tissue. Equation 12 reveals that the magnitude of Ki values is determined by cellularity of individual organs and tissues and their corresponding Ji values.

Our results showed that the Ki values in the obese women were lower by 2.0% (i.e., O = 0.980) compared to Elia’s Ki values. According to equation 12, there are two possible explanations for this observation. First, the low Ki values in obese adults may be caused by low Ji values. Although there is a need to measure the Ji values of individual cell categories, in vivo quantification of the Ji values requires noninvasive methods that remain technically demanding (17,18). Positron emission tomography with 15O or 11C markers may allow for in vivo quantification of organ/tissue energy consumption (19). Further study is needed to measure the Ji values of major organs and tissues in normal-weight and obese adults.

Second, the cellularity of individual organs and tissues may be lower in the obese adults than in nonobese adults, due to fatty infiltration. In support of this explanation, previous studies reported an increase in the amount of lipid contained with skeletal muscle fibers and liver in obese adults (2022). In the present study, MRI cross-sectional scans were segmented manually, and small amounts of adipose tissue within skeletal muscle bundles (i.e., intra-muscular adipose tissue, IMAT) were removed. However, small area of IMAT may remain within SM cross-sectional area that cannot be manually removed that causes a relatively low cellularity in obese adults. In nonobese adults, for example, the cellularity of IMAT-free skeletal muscle can be assumed as 0.60 (i.e., CSM/TSM = 0.60). Giving 3% IMAT in skeletal muscle, its cellularity decreases from 0.60 to 0.58, (i.e., CSM/(1.03 × TSM) = 0.58). Assuming the Ji value remains stable, according to equation 12, the corresponding Ki value decreases by about 2% in obesity. As the MRI protocol applied in the present study is not able to determine the concentration of fat within organs and tissues, further study is needed to estimate the fat content of major organs and tissues by using noninvasive techniques such as 1H-magnitic resonance spectroscopy (20).

There is another limitation in the present study. In some subjects, adipose tissue mass was calculated from dual-energy X-ray absorptiometry fat estimation, based on an assumption of a constant fat content (80%) in adipose tissue (14). However, a higher fat content of adipose tissue in obese subjects would lead to an overestimation of adipose tissue mass and corresponding underestimation of residual mass.

In conclusion, although applicable in nonelderly nonobese adults, Elia’s study overestimates the Ki values by 2% in obese adults, so that obesity-modified Ki values should be applied. This study thus helps to understand the inherent relationship between REE and body composition in obese adults. A more comprehensive and precise quantification of the association between Ki values and adiposity is certainly an important topic for future studies.

Acknowledgments

We are grateful to those subjects who participated in this study. We also thank the reviewers for constructive suggestions on revising our manuscript. This project was supported by award DK081633 from the USA National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and German Research Foundation DFG Mu 714/8-3. The content is the responsibility of the authors and does not necessarily represent the official views of NIDDK or German Research Foundation.

Footnotes

DISCLOSURE

The authors declared no conflict of interest.

References

1. Elia M. Organ and tissue contribution to metabolic rate. In: Kinney JM, Tucker HN, editors. Energy Metabolism: Tissue Determinants and Cellular Corollaries. Raven Press; New York: 1992. pp. 61–80. [Google Scholar]
2. FAO/WHO/UNU. Human Energy Requirements. Report of Joint FAO/WHO/UNU Expert Consultation; Rome. 2004. pp. 35–50. [Google Scholar]
3. Wang Z, Heshka S, Heymsfield SB, Shen W, Gallagher D. A cellular-level approach to predicting resting energy expenditure across the adult years. Am J Clin Nutr. 2005;81:799–806. [PubMed] [Google Scholar]
4. Gallagher D, Allen A, Wang Z, Heymsfield SB, Krasnow N. Smaller organ tissue mass in the elderly fails to explain lower resting metabolic rate. Ann N Y Acad Sci. 2000;904:449–455. [PubMed] [Google Scholar]
5. Hsu A, Heshka S, Janumala I, et al. Larger mass of high-metabolic-rate organs does not explain higher resting energy expenditure in children. Am J Clin Nutr. 2003;77:1506–1511. [PubMed] [Google Scholar]
6. Wang Z, Heymsfield SB, Ying Z, et al. A cellular level approach to predicting resting energy expenditure: Evaluation of applicability in adolescents. Am J Hum Biol. 2010;22:476–483. [PMC free article] [PubMed] [Google Scholar]
7. Gallagher D, Belmonte D, Deurenberg P, et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol. 1998;275:E249–E258. [PubMed] [Google Scholar]
8. Wang Z, Heshka S, Zhang K, Boozer CN, Heymsfield SB. Resting energy expenditure: systematic organization and critique of prediction methods. Obes Res. 2001;9:331–336. [PubMed] [Google Scholar]
9. Weisberg S. Applied Linear Regression. 3. John Wileys & Sons; NJ: 2005. [Google Scholar]
10. Bosy-Westphal A, Reinecke U, Schlörke T, et al. Effect of organ and tissue masses on resting energy expenditure in underweight, normal weight and obese adults. Int J Obes. 2004;28:72–79. [PubMed] [Google Scholar]
11. Later W, Bosy-Westphal A, Hitze B, et al. No evidence of mass dependency of specific organ metabolic rate in healthy humans. Am J Clin Nutr. 2008;88:1004–1009. [PubMed] [Google Scholar]
12. Heymsfield SB, Ross R, Wang ZM, Frager D. Imaging techniques of body composition: Advantages of measurement and new uses. In: Carlson-Newberry SJ, Costello RB, editors. Imaging Technologies for Nutrition Research. National Academy Press; Washington, DC: 1997. pp. 127–150. [Google Scholar]
13. Kim J, Wang ZM, Heymsfield ZM, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: Estimation by new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002;76:378–383. [PubMed] [Google Scholar]
14. Snyder WS, Cook MJ, Nasset ES, Karhausen LR, Howells GP, et al. Report of the Task Group on Reference Man. Pergamon Press; Oxford: 1975. [Google Scholar]
15. Maindonald J, Braun J. Data Analysis and Graphics Using R. 3. Cambridge University Press; London, UK: 2010. [Google Scholar]
16. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–723. [Google Scholar]
17. Linde B, Hjemdahl P, Freyschuss U, Juhlin-Dannfelt A. Adipose tissue and skeletal muscle blood flow during mental stress. Am J Physiol. 1989;256:E12–E18. [PubMed] [Google Scholar]
18. McCully KK, Posner JD. The application of blood flow measurements to the study of aging muscle. J Gerontol A Biol Sci Med Sci. 1995;50(Spec No):130–136. [PubMed] [Google Scholar]
19. Gallagher D. Body composition, organ mass, and resting energy expenditure. In: Heymsfield SB, Lohman TG, Wang ZM, Going SB, editors. Human Body Composition. 2. Human Kinetics; Champaign, IL: 2005. pp. 219–239. [Google Scholar]
20. Bosy-Westphal A, Kossel E, Goele K, et al. Association of pericardial fat with liver fat and insulin sensitivity after diet-induced weight loss in overweight women. Obesity (Silver Spring) 2010;18:2111–2117. [PubMed] [Google Scholar]
21. Hulver MW, Berggren JR, Cortright RN, et al. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab. 2003;284:E741–E747. [PubMed] [Google Scholar]
22. Kelley DE, Storlien L. Skeletal muscle and obesity. In: Bray GA, Bouchard C, editors. Handbook of Obesity. Marcel Dekker; New York: 2004. pp. 733–752. [Google Scholar]

Formats: